FDA Inspection 1035495 — Bloodworks

Bloodworks — FEI 3005996806

The FDA completed an inspection of Bloodworks on December 20, 2017 in Vancouver, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 20, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Vancouver, WA (United States)

Citations

IDCFRDescription
1813421 CFR 640.21(g)Informed consent